These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25129277)

  • 1. The Anp genetic variant Rs5068 and circulating levels of natriuretic peptides in patients with chronic heart failure.
    Cannone V; Barlera S; Pileggi S; Masson S; Franzosi MG; Latini R; Scardulla C; Clemenza F; Maggioni AP; Nicolosi GL; Tavazzi L; Burnett JC;
    Int J Cardiol; 2014 Oct; 176(3):1249-51. PubMed ID: 25129277
    [No Abstract]   [Full Text] [Related]  

  • 2. Sex-based differences in metabolic protection by the ANP genetic variant rs5068 in the general population.
    Ichiki T; Cannone V; Scott CG; Iyer SR; Sangaralingham SJ; Bailey KR; Goetze JP; Tsuji Y; Rodeheffer RJ; Burnett JC
    Am J Physiol Heart Circ Physiol; 2023 Sep; 325(3):H545-H552. PubMed ID: 37417873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure.
    Newton-Cheh C; Larson MG; Vasan RS; Levy D; Bloch KD; Surti A; Guiducci C; Kathiresan S; Benjamin EJ; Struck J; Morgenthaler NG; Bergmann A; Blankenberg S; Kee F; Nilsson P; Yin X; Peltonen L; Vartiainen E; Salomaa V; Hirschhorn JN; Melander O; Wang TJ
    Nat Genet; 2009 Mar; 41(3):348-53. PubMed ID: 19219041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community.
    Cannone V; Boerrigter G; Cataliotti A; Costello-Boerrigter LC; Olson TM; McKie PM; Heublein DM; Lahr BD; Bailey KR; Averna M; Redfield MM; Rodeheffer RJ; Burnett JC
    J Am Coll Cardiol; 2011 Aug; 58(6):629-36. PubMed ID: 21798427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial natriuretic peptide and type 2 diabetes development--biomarker and genotype association study.
    Jujić A; Nilsson PM; Engström G; Hedblad B; Melander O; Magnusson M
    PLoS One; 2014; 9(2):e89201. PubMed ID: 24586593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renal and cardiovascular effects of natriuretic peptides.
    Wong PC; Guo J; Zhang A
    Adv Physiol Educ; 2017 Jun; 41(2):179-185. PubMed ID: 28377431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A favorable cardiometabolic profile is associated with the G allele of the genetic variant rs5068 in African Americans: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Cannone V; Scott CG; Decker PA; Larson NB; Palmas W; Taylor KD; Wang TJ; Gupta DK; Bielinski SJ; Burnett JC
    PLoS One; 2017; 12(12):e0189858. PubMed ID: 29253899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers.
    Gwechenberger M; Huelsmann M; Graf S; Berger R; Bonderman D; Stanek B; Rauscha F; Pacher R
    Eur J Clin Invest; 2004 Dec; 34(12):811-7. PubMed ID: 15606723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure.
    Hystad ME; Geiran OR; Attramadal H; Spurkland A; Vege A ; Simonsen S; Hall C
    Acta Physiol Scand; 2001 Apr; 171(4):395-403. PubMed ID: 11421854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP.
    Hogenhuis J; Voors AA; Jaarsma T; Hillege HL; Boomsma F; van Veldhuisen DJ
    Eur J Heart Fail; 2005 Jan; 7(1):81-6. PubMed ID: 15642536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in the natriuretic peptide system and heart failure.
    Lanfear DE
    Heart Fail Rev; 2010 May; 15(3):219-28. PubMed ID: 18850266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genetic variant of the atrial natriuretic peptide gene is associated with left ventricular hypertrophy in a non-diabetic population--the Malmö preventive project study.
    Jujić A; Leosdottir M; Östling G; Gudmundsson P; Nilsson PM; Melander O; Magnusson M
    BMC Med Genet; 2013 Jun; 14():64. PubMed ID: 23799939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The atrial natriuretic peptide genetic variant rs5068 is associated with a favorable cardiometabolic phenotype in a Mediterranean population.
    Cannone V; Cefalu' AB; Noto D; Scott CG; Bailey KR; Cavera G; Pagano M; Sapienza M; Averna MR; Burnett JC
    Diabetes Care; 2013 Sep; 36(9):2850-6. PubMed ID: 23637347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses of atrial natriuretic peptide and brain natriuretic peptide to exercise in patients with chronic heart failure and normal control subjects.
    Steele IC; McDowell G; Moore A; Campbell NP; Shaw C; Buchanan KD; Nicholls DP
    Eur J Clin Invest; 1997 Apr; 27(4):270-6. PubMed ID: 9134374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure.
    Voors AA; Petrie CJ; Petrie MC; Charlesworth A; Hillege HL; Zijlstra F; McMurray JJ; van Veldhuisen DJ
    Eur Heart J; 2005 Sep; 26(17):1759-64. PubMed ID: 15833758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial natriuretic peptide is negatively regulated by microRNA-425.
    Arora P; Wu C; Khan AM; Bloch DB; Davis-Dusenbery BN; Ghorbani A; Spagnolli E; Martinez A; Ryan A; Tainsh LT; Kim S; Rong J; Huan T; Freedman JE; Levy D; Miller KK; Hata A; Del Monte F; Vandenwijngaert S; Swinnen M; Janssens S; Holmes TM; Buys ES; Bloch KD; Newton-Cheh C; Wang TJ
    J Clin Invest; 2013 Aug; 123(8):3378-82. PubMed ID: 23867623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure.
    Mair J; Hammerer-Lercher A; Puschendorf B
    Clin Chem Lab Med; 2001 Jul; 39(7):571-88. PubMed ID: 11522102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of natriuretic peptides for acute heart failure: a review.
    Zhou SL; Zhang J; Song TT; Li X; Wang HX
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2415-2420. PubMed ID: 29762843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.
    Clerico A; Iervasi G; Del Chicca MG; Emdin M; Maffei S; Nannipieri M; Sabatino L; Forini F; Manfredi C; Donato L
    J Endocrinol Invest; 1998 Mar; 21(3):170-9. PubMed ID: 9591213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.